Natural recovery and protection from autoimmune encephalomyelitis: Contribution of CD4+CD25+ regulatory cells within the central nervous system

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 3025-3032

  McGeachy, Mandy J ^a   Stephens, Leigh A ^a   Anderton, Stephen M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAEBETA7 INTEGRIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR FAMILY RELATED PROTEIN; INTEGRIN; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL TRANSFER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; IMMUNOREGULATION; LYMPHOCYTE COUNT; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE;

EID: 23844478869     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.3025     Document Type: Article

References (38)

1. Mendel, I., N. Kerlero de Rosbo, and A. Ben-Nun. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V β expression of encephalitogenic T cells. Eur. J. Immunol. 25: 1951-1959.
2. MacPhee, I. A., F. A. Antoni, and D. W. Mason. 1989. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169: 431-445.
3. O'Brien, N. C., B. Charlton, W. B. Cowden, and D. O. Willenborg. 1999. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction. J. Immunol. 163: 6841-6847.
4. Lenz, D. C., and R. H. Swanborg. 1999. Suppressor cells in demyelinating disease: a new paradigm for the new millennium. J. Neuroimmunol. 100: 53-57.
5. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
6. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161: 3299-3306.
7. Jander, S., J. Pohl, D. D'Urso, C. Gillen, and G. Stoll. 1998. Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. Am. J. Pathol. 152: 975-982.
8. Cua, D. J., B. Hutchins, D. M. LaFace, S. A. Stohlman, and R. L. Coffman. 2001. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166: 602-608.
9. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278.
10. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
11. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
12. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
13. + Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16: 183-191.
14. + regulatory T cells in vivo. J. Exp. Med. 198: 249-258.
15. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198: 235-247.
16. Klein, L., K. Khazaie, and H. von Boehmer. 2003. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100: 8886-8891.
17. + regulatory T cells in the steady state. J. Exp. Med. 198: 737-746.
18. + regulatory T cells. J. Immunol. 170: 3939-3943.
19. + regulatory T cells. J. Exp. Med. 199: 303-313.
20. + as well as CD25-regulatory T cells. Proc. Natl. Acad. Sci. USA 99: 13031-13036.
21. + regulatory T cells. Nat. Immunol. 4: 330-336.
22. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
23. + T regulatory cells. Nat. Immunol. 4: 337-342.
24. Hinrichs, D. J., C. M. Roberts, and F. J. Waxman. 1981. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction. J. Immunol. 126: 1857-1862.
25. + regulatory T. cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
26. + regulatory T cells. Int. Immunol. 16: 249-256.
27. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164: 183-190.
28. Furtado, G. C., D. Olivares-Villagomez, M. A. Curotto de Lafaille, A. K. Wensky, J. A. Latkowski, and J. J. Lafaille. 2001. Regulatory T cells in spontaneous autoimmune encephalomyelitis. Immunol. Rev. 182: 122-134.
29. + T cells: analysis using depleting antibodies. J. Autoimmun. 23: 1-7.
30. + T cell activation and experimental autoimmune encephalomyelitis. J. Immunol. 172: 4686-4690.
31. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465.
32. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199: 1467-1477.
33. + suppressor T cells in vivo. Nat. Immunol. 3: 33-41.
34. + regulatory T cells cure murine colitis: the role of IL-10, TGF-β, and CTLA4. J. Immunol. 171: 5012-5017.
35. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199: 971-979.
36. 25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 172: 6435-6443.
37. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6: R335-R346.
38. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197: 111-119.